Navigation Links
CT-guided irreversible electroporation safe in unresectable pancreatic carcinoma
Date:5/7/2014

Leesburg, VA, May 6, 2014A small group of patients with locally advanced unresectable pancreatic carcinoma suffered no major ill effectspancreatitis or fistula formationafter undergoing percutaneous CT-guided irreversible electroporation (IRE)a nonthermal ablation technology that is safe near vascular and ductal structuresas a therapy.

"Our findings exceeded our expectations," said Maria Paola Belfiore, a researcher at the Institute of Radiology, Second University of Naples. "In fact, three patients were downstaged, and so had a greater life expectancy. This is a great new promise for inoperable pancreatic tumors."

The ablation procedure was successful in 100 percent of the patients. These early results represent a good alternative to intraoperative IRE ablation, and offer a safe and feasible primary local treatment for locally advanced pancreatic cancer.


'/>"/>

Contact: Lissa D. Hurwitz
lhurwitz@arrs.org
American Roentgen Ray Society
Source:Eurekalert

Page: 1

Related medicine news :

1. Vaginal Mesh Lawsuit Filed by Wright & Schulte LLC on Behalf of a Nebraska Woman Alleging Her Irreversible Injuries Were Caused by Boston Scientific’s Transvaginal Mesh
2. Transvaginal Mesh Lawsuit Filed by Wright & Schulte Alleges that Boston Scientific’s Defective Mesh Sling Caused New York Woman to Suffer Serious, Irreversible Injuries
3. Transvaginal Mesh Lawsuit Filed by Wright & Schulte LLC on Behalf of Michigan Woman Alleging the Defective Design of Ethicon’s Mesh Sling Caused Irreversible Injuries
4. Study: Ipilimumab Shows Durable Responses But Low Overall Response Rate In Patients With Unresectable Or Metastatic Mucosal Melanoma
5. Short Walks May Ease Fatigue in Pancreatic Cancer Patients
6. Mutant Kras drives pancreatic cancer maintenance via metabolic pathways
7. Early biomarker for pancreatic cancer identified
8. Researchers present new findings for novel pancreatic cancer vaccine
9. Studies See Advances in Detecting, Treating Pancreatic Cancer
10. Nerve growth factors elevated in pancreatic cancer model
11. Sun exposure and sun-sensitive skin type decreased risk for pancreatic cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... (PRWEB) , ... February 08, 2016 , ... Guruji Mahendra ... 9th, 10th and 11th, 2016 in honor of his birthday on February 10th. ... happiness. Mahendra Trivedi is known by over 250,000 people from over 40 different ...
(Date:2/7/2016)... ... February 07, 2016 , ... Women’s Excellence now ... the most minimally invasive approaches. , Women who have had multiple vaginal births ... factors include surgery to the pelvic floor, connective tissue disorders, and obesity. Women ...
(Date:2/7/2016)... ... February 07, 2016 , ... Dr. Todd Hobgood , ... medical and surgical expertise. Technically known as deoxycholic acid or previously as ATX-101, ... non-surgical alternative for reduction of fat below the chin (aka the “double chin”). ...
(Date:2/6/2016)... ... February 06, 2016 , ... With the FCPX ... warm color grades to their footage. A LUT is a Lookup Table that contains ... the corresponding color indicated by the table. By manipulating each pixel, LUT's can change ...
(Date:2/5/2016)... ... , ... Steven Tonkinson, 36, of Coconut Grove, Florida, ran the Miami Marathon ... 2003. This year, he ran all 26.2 miles with a green 25-pound ShelterBox strapped ... Heat. , This Sunday, while many are watching the Superbowl, Steven Tonkinson will strap ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... -- HemaFlo Therapeutics, Inc. announced today that the United States Patent ... covering the use of NephroFlow to treat acute kidney injury ... said, "We are pleased to secure our rights to such ... PhD, HemaFlo,s founder, said, "We are pleased to secure our ... Dale Peterson , PhD, HemaFlo,s founder, said, "We are ...
(Date:2/8/2016)... , Feb. 8, 2016  Dynatronics Corporation ... of advanced-technology medical devices and rehabilitation equipment for ... congratulates the Denver Broncos, football team for winning ... Cullimore Jr. , Chairman and Chief Executive Officer.  ... and we look forward to enhancing their athletic ...
(Date:2/8/2016)... , Feb. 8, 2016  Sangamo BioSciences, ... therapeutic genome editing, announced that the U.S. Food ... Investigational New Drug (IND) application for SB-318, a ... therapy for Mucopolysaccharidosis Type I (MPS I). The ... Sangamo to initiate a Phase 1/2 clinical study ...
Breaking Medicine Technology: